Optomed Oyj (HEL:OPTOMED)
Finland flag Finland · Delayed Price · Currency is EUR
2.610
+0.070 (2.76%)
At close: Mar 4, 2026

Optomed Oyj Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
17.115.0415.114.6614.85
17.115.0415.114.6614.85
Revenue Growth (YoY)
13.67%-0.40%3.00%-1.28%12.77%
Cost of Revenue
6.225.374.865.455.1
Gross Profit
10.879.6710.249.219.75
Selling, General & Admin
10.829.649.339.619.38
Other Operating Expenses
3.583.492.692.392.91
Operating Expenses
16.9215.4314.214.1114.5
Operating Income
-6.04-5.77-3.95-4.9-4.75
Interest Expense
-0.11-0.16-0.2-0.12-0.1
Interest & Investment Income
0.120.180.0200.02
Currency Exchange Gain (Loss)
-0.340.5-0.31-0.20.47
Other Non Operating Income (Expenses)
-0.34-0.08-0.05-0.150.07
EBT Excluding Unusual Items
-6.72-5.33-4.5-5.35-4.29
Asset Writedown
--0.19-0.02-1.04-0.57
Other Unusual Items
---0.840.54
Pretax Income
-6.72-5.52-4.52-5.55-4.33
Income Tax Expense
-0.08-0.07-0.08-0.08-0.08
Earnings From Continuing Operations
-6.64-5.45-4.44-5.47-4.25
Net Income to Company
-6.64-5.45-4.44-5.47-4.25
Net Income
-6.64-5.45-4.44-5.47-4.25
Net Income to Common
-6.64-5.45-4.44-5.47-4.25
Shares Outstanding (Basic)
2019171513
Shares Outstanding (Diluted)
2019171513
Shares Change (YoY)
6.08%11.78%14.11%8.92%1.35%
EPS (Basic)
-0.34-0.29-0.27-0.37-0.32
EPS (Diluted)
-0.34-0.29-0.27-0.37-0.32
Free Cash Flow
-3.04-1.87-0.83-3.15-3.4
Free Cash Flow Per Share
-0.15-0.10-0.05-0.21-0.25
Gross Margin
63.61%64.27%67.83%62.83%65.64%
Operating Margin
-35.34%-38.34%-26.18%-33.41%-31.97%
Profit Margin
-38.84%-36.24%-29.41%-37.33%-28.61%
Free Cash Flow Margin
-17.80%-12.44%-5.48%-21.49%-22.91%
EBITDA
-5.34-5.1-3.28-4.12-3.99
EBITDA Margin
-31.25%-33.88%-21.69%-28.10%-26.87%
D&A For EBITDA
0.70.670.680.780.76
EBIT
-6.04-5.77-3.95-4.9-4.75
EBIT Margin
-35.34%-38.34%-26.18%-33.41%-31.97%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.